10 results
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
2021 ACR/VF Guidelines ... Polyangiitis (MPA ... #ACR2021 #Management ... #rheumatology # ... algorithm #vasculitis
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management - ACR ... Polyangiitis (MPA ... Management #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Granulomatosis with ... Polyangiitis (MPA ... - ACR/VF 2021 Guidelines ... Management #Treatment #ACR2021 ... #rheumatology
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
2021 ACR/VF Guidelines ... of Eosinophilic Granulomatosis ... #Polyangiitis #ACR2021 ... #Management #rheumatology ... #algorithm #vasculitis
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Eosinophilic Granulomatosis ... Vasculitis Management Algorithm ... - ACR/VF 2021 Guidelines ... Management #Treatment #ACR2021 ... #rheumatology
Inflammatory Joint Pain - Differential Diagnosis Algorithm 
Monoarticular
 • Gout (Podagra, Tophi)
 • Pseudogout
 • Early
- Differential Diagnosis ... Algorithm Monoarticular ... Arthritis • Systemic Lupus ... Rheumatica • Granulomatosis ... #Algorithm #Orthopedics
ANA (Antinuclear Antibody) and ANCA (Antineutrophil cytoplasmic antibodies)
 • Systemic lupus erythematosus
   1. Anti-dsDNA
) • Systemic lupus ... scleroderma) - Anti-Scl ... ANCA+ 90% • Granulomatosis ... Antineutrophil #antibodies #diagnosis ... #rheumatology #
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
Epidemiology: -10% of all ... thiazidic, PPI, ACE ... - pANCA anti-MPO ... comparison #table #rheumatology ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
dependent DM ACS ... event, follow ACC ... algorithm to determine ... indication of AC ... • <12mo since ACS
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
Drug Induced Lupus ... thiazidic, PPI, ACE ... - pANCA anti-MPO ... #DIL #rheumatology ... #diagnosis #treatment